Dedication
This report is dedicated to Spencer Cox March 10, 1968–December 18, 2012 Walter Kurtz Photography © 2006 Remarks on the Naming of the Spencer Cox Center for Health Melanie Thompson, MD New York City, June 11, 2013 I am so…
Introduction and Executive Summary
July 2014 By Polly Clayden and Mark Harrington INTRODUCTION Last year we wrote: [Getting] the best drugs to the most people as quickly as possible… requires that the compounds and combination products be: Discovered and developed in a high-quality research…
Dedication
July 2014 This report is dedicated to Marvin Oscar Shulman May 17, 1932–January 15, 2014 Marvin pictured, seated, second from left. A fierce AIDS warrior, principled leader, and beloved friend, Marvin Shulman was an activist’s activist. He dedicated himself completely…
Dedication
THIS REPORT IS DEDICATED TO Tireless Champion of Disadvantaged and Vulnerable People Ana Isabel Charle (1979–2015) and Pioneering HIV Researcher and Activist Joseph Albert Marie “Joep” Lange (1954–2014)
Executive Summary
July 15, 2016 By Mark Harrington Executive Summary - HIV THE ANTIRETROVIRAL TREATMENT PIPELINE In their chapter on Antiretroviral Treatment in this year’s Pipeline Report [9], Tim Horn and Simon Collins provide a sweeping overview of developments in the past…
Dedications
THIS REPORT IS DEDICATED TO Margie Garber-Steinberg April 7, 1949 – April 14, 2016 This edition of the Pipeline Report is dedicated to Margie Garber-Steinberg, mother of long-time board member Jason Osher. Margie was a steadfast TAG supporter for…
Introduction and Executive Summary
July 2012 By Polly Clayden and Mark Harrington In nine countries, we enrolled 1763 couples in which one partner was HIV-1–positive and the other was HIV-1–negative; 54% of the subjects were from Africa, and 50% of infected partners were men…
Introduction and Executive Summary
July 2017 By Mark Harrington INTRODUCTION This year marks the 30th year since the U.S. Food and Drug Administration (FDA) granted a license for Burroughs-Wellcome to market AZT (zidovudine, Retrovir), the first approved drug to treat HIV infection, at the…